Table 1.
Demographic and clinical characteristics of ET cases and controls
| All ET Cases
(N = 267) |
All Controls
(N = 331) |
ET Cases with Harmane Data
(N = 147) |
Controls with Harmane Data
(N = 187) |
|
|---|---|---|---|---|
|
| ||||
| Demographic and Clinical Characteristics | ||||
|
| ||||
| Age in years | 68.5 ± 14.4 | 66.6 ± 13.1 | 67.7 ± 14.6* | 64.0 ± 13.8 |
|
| ||||
| Female gender | 145 (54.3%) | 194 (58.6%) | 81 (55.1%) | 107 (57.2%) |
|
| ||||
| Years of education | 14.8 ± 4.1 | 15.1 ± 3.5 | 15.0 ± 4.0 | 15.2 ± 3.6 |
|
| ||||
| Current cigarette smoker | 16 (6.0%) | 30 (9.1%) | 10 (6.8%) | 18 (9.6%) |
|
| ||||
| Ever cigarette smoker | 131 (49.1%) | 169 (51.1%) | 75 (51.0%) | 98 (52.4%) |
|
| ||||
| Cigarette pack-years | 9.4 ± 19.6 | 11.0 ± 21.8 | 8.0 ± 17.9 | 9.6 ± 20.3 |
|
| ||||
| Years since last hospitalization | 13.9 ± 20.5 | 14.6 ± 19.9 | 13.8 ± 18.9 | 14.5 ± 18.9 |
|
| ||||
| Cumulative Illness Rating Scale Score | 5.6 ± 3.7 | 5.3 ± 3.7 | 5.4 ± 3.7 | 5.0 ± 3.8 |
|
| ||||
| Cancer | ||||
|
| ||||
| Cancer | 66 (24.7%) | 55 (16.6%) | ||
| Colon* | 7 (2.6%) | 2 (0.6%) | ||
| Skin | 22 (8.2%) | 17 (5.1%) | ||
| Melanoma | 8 (3.0%) | 9 (2.7%) | ||
| Basal Cell Carcinoma | 9 (3.4%) | 4 (1.2%) | ||
| Squamous Cell Carcinoma | 4 (1.5%) | 3 (0.9%) | ||
| Basal and Squamous | 1 (0.4%) | 1 (0.3%) | ||
| Prostate | 8 (3.0%) | 7 (2.1%) | ||
| Breast | 18 (6.7%) | 22 (6.6%) | ||
| Uterine/ovarian | 4 (1.5%) | 4 (1.2%) | ||
| Lung | 1 (1.4%) | 0 (0.0%) | ||
| Other** | 6 (2.2%) | 3 (0.9%) | ||
*
p < 0.05 compared with controls (χ2 and t tests).
**
including bladder, brain, kidney, thyroid, and lymphoma/leukemia.